FBIOP vs OGN · $44.3M cap vs P/E 3.4, rev $3.02B
Fortress Biotech Inc Pref Series A (FBIOP) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
FBIOP does not have a complete income-statement cache yet.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
FBIOP currently screens at market cap $44.3M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the FBIOP and OGN stock pages for the full models.
Not investment advice.